688799 华纳药厂
2026/03 - 三个月
人民幣(K¥)
与去年同期
比较
2025/12
人民幣(K¥)
2024/12
人民幣(K¥)
2023/12
人民幣(K¥)
2022/12
人民幣(K¥)
营业总收入324,546-3.48%1,504,2311,412,9491,432,7891,292,662
减:营业总成本292,516-0.58%1,359,7461,256,3901,210,0311,111,304
    其中:营业成本138,64012.17%597,400542,148504,552417,378
               财务费用150-104.86%(211)(17,125)(12,323)(7,604)
               资产减值损失(3,991)38,558.90%(8,833)(11,114)(7,593)(4,532)
公允价值变动收益------------
投资收益(573)-207.01%84,335(18,662)3,5857,975
    其中:对联营企业和合营企业的投资收益(2,479)83.47%(23,362)(18,748)--(4,762)
营业利润33,190-28.70%240,485161,766237,115196,005
利润总额33,189-28.69%240,895161,676229,879194,963
减:所得税费用6,312-32.07%12,79722,91636,84321,573
净利润26,877-27.84%228,098138,760193,037173,390
减:非控股权益----(10,181)(25,557)(18,283)(9,415)
股东净利润26,877-34.79%238,279164,317211,320182,805

市场价值指针
每股收益 (元) *0.200-35.48%1.8101.2502.2501.950
每股派息 (元) *----0.1820.6000.9000.900
每股净资产 (元) *15.807-19.98%15.55519.22618.37417.021
审计意见 #--标准无保留意见标准无保留意见标准无保留意见标准无保留意见
回页顶
备注: *未调整数据
#只提供简体内容